Sleeping With a Pacifier Lowers SIDS Risk

Babies should be put to sleep on their backs and offered a pacifier, and they should not sleep overnight in the same bed with their parents, according to surprising new guidelines designed to prevent sudden infant death syndrome (SIDS).

SIDS Cases Rise During Winter

Don't cover babies with extra blankets or clothes during winter because of the risk of SIDS (sudden infant death syndrome). That advice comes from the National Institute of Child Health and Human Development (NICHD), a branch of the National Institutes of Health (NIH).

Longer SIDS Risk for Premature Babies

Premature babies may be at risk for SIDS (sudden infant death syndrome) longer than full-term babies, a new study shows. SIDS is the sudden, unexpected death of a baby less than 1 year old with no explanation from a thorough investigation.

SIDS Linked With Loss of Hypoxic Sensitivity in Chromaffin Cells

The association between maternal smoking, or exposure to smoke, and sudden infant death syndrome (SIDS) appears to be the result of nicotine exposure, which impairs chromaffin cells' ability to detect and respond to oxygen deprivation, the results of an animal study suggest.

SIDS Linked to Early Atherosclerosis

Sudden infant death syndrome (SIDS) appears to be associated with early atherosclerotic lesions, according to a study presented on Sunday at the Argentine Congress of Cardiology. However, the mechanism of the association is unclear, the researchers said.

SIDS Risk Higher in Infants of HIV-Positive Women Who Use Opiates

Risk for sudden infant death syndrome (SIDS) is 69 times higher for babies of HIV-positive women who used opiates during pregnancy than in the general population of similarly aged infants, Swiss researchers report in the November issue of the Archives of the Disease in Childhood. Increased SIDS risk did not appear to be mediated by […]

U.S. Lawmakers Probe FDA Approval of Ranbaxy Drugs

Two leading U.S. Democrats said on Tuesday they are investigating whether Food and Drug Administration knowingly allowed the sale of Ranbaxy drugs that may have been backed by fraudulent data. The congressional investigation stems from information released as part of a probe by U.S. law enforcement authorities into whether the Indian drugmaker submitted false data […]